Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

duopharma manufacturing (bangi) sdn bhd - codeine phosphate; paracetamol -

Israel - English - Ministry of Health

lundbeck israel ltd. - zuclopenthixol acetate - solution for injection - zuclopenthixol acetate 50 mg/ml - zuclopenthixol - zuclopenthixol - acute psychoses.

United States - English - NLM (National Library of Medicine)

trupharma, llc - paroxetine hydrochloride anhydrous (unii: 3i3t11ud2s) (paroxetine - unii:41vrh5220h) - paroxetine 10 mg - major depressive disorder: paroxetine tablets are indicated for the treatment of major depressive disorder. the efficacy of paroxetine tablets in the treatment of a major depressive episode was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical pharmacology: clinical trials ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the effects of paroxetine tablets in hospitalized depressed patients have not been adequately studied.

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

schering -

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

schering -

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

schering -

United States - English - NLM (National Library of Medicine)

trupharma, llc - venlafaxine hydrochloride (unii: 7d7rx5a8mo) (venlafaxine - unii:grz5rcb1qg) - venlafaxine 25 mg - venlafaxine tablets, usp are indicated for the treatment of major depressive disorder. the efficacy of venlafaxine tablets, usp in the treatment of major depressive disorder was established in 6-week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm-iii or dsm-iii-r category of major depression and in a 4-week controlled trial of inpatients meeting diagnostic criteria for major depression with melancholia (see clinical trials ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the efficacy of ve

Australia - English - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - zuclopenthixol acetate, quantity: 100 mg (equivalent: zuclopenthixol, qty 90.5 mg) - injection, solution - excipient ingredients: fractionated coconut oil - initial treatment of acute psychoses, mania and exacerbation of chronic psychoses.

Australia - English - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - zuclopenthixol acetate, quantity: 50 mg (equivalent: zuclopenthixol, qty 45.25 mg) - injection, solution - excipient ingredients: fractionated coconut oil - initial treatment of acute psychoses, mania and exacerbation of chronic psychoses.

United Kingdom - English - VMD (Veterinary Medicines Directorate)

ecuphar nv - hydrocortisone aceponate - cutaneous spray, solution - anti inflammatory corticosteroid - dogs